174407-98-8

Basic information

• Product Name: 2,5-Pyrrolidinedione, 1-[3-[4-(4-methoxyphenyl)-6-(1H-pyrazol-1-yl)-1H-furo[3,4-d]imidazol-2-yl]phenyl]-3-octadecyl-
• Synonyms: 2,5-Pyrrolidinedione, 1-[3-[4-(4-methoxyphenyl)-6-(1H-pyrazol-1-yl)-1H-furo[3,4-d]imidazol-2-yl]phenyl]-3-octadecyl-
• CAS NO: 174407-98-8
• Molecular Formula: C43H55N5O4
• Molecular Weight: 0
• Mol File: 174407-98-8.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,5-Pyrrolidinedione, 1-[3-[4-(4-methoxyphenyl)-6-(1H-pyrazol-1-yl)-1H-furo[3,4-d]imidazol-2-yl]phenyl]-3-octadecyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 2,5-Pyrrolidinedione, 1-[3-[4-(4-methoxyphenyl)-6-(1H-pyrazol-1-yl)-1H-furo[3,4-d]imidazol-2-yl]phenyl]-3-octadecyl-(174407-98-8)
• EPA Substance Registry System: 2,5-Pyrrolidinedione, 1-[3-[4-(4-methoxyphenyl)-6-(1H-pyrazol-1-yl)-1H-furo[3,4-d]imidazol-2-yl]phenyl]-3-octadecyl-(174407-98-8)

Safety Data

• Hazardous Substances Data: 174407-98-8(Hazardous Substances Data)

Usage

Molecular structure

2,5-Pyrrolidinedione core with various substituents

Pyrrolidinedione ring

A five-membered ring with two carbonyl groups (C=O) at positions 2 and 5

Methoxyphenyl group

A phenyl ring with a methoxy (-OCH3) substituent at position 4

Pyrazol-1-yl group

A five-membered ring with a nitrogen atom at position 1, adjacent to a carbonyl group

Furo[3,4-d]imidazol-2-yl group

A fused bicyclic ring system consisting of a furan ring and an imidazole ring

Octadecyl side chain

An 18-carbon alkyl chain

Aromatic rings

Phenyl and furan rings contribute to the compound's stability and potential biological activity

Carbonyl groups

Present in the pyrrolidinedione ring and the furo[3,4-d]imidazol-2-yl group, which may participate in hydrogen bonding and coordination with metal ions

Biological

The compound's complex structure and various functional groups may allow it to interact with biological targets, such as enzymes or receptors

Pharmaceutical

The compound could be further modified or used as a scaffold for the development of new drugs with therapeutic potential

Synthesis

Optimizing the synthesis of the compound to improve yield and purity

Characterization

Determining the compound's physical and chemical properties, such as solubility, stability, and reactivity

Biological evaluation

Testing the compound's activity against specific biological targets or in cell-based assays to assess its potential as a therapeutic agent

Safety and handling

Due to the complexity of the compound, appropriate safety precautions should be taken when handling, such as wearing gloves, protective eyewear, and using a fume hood for volatile or hazardous reactions